51 results
8-K
SLRN
Acelyrin Inc
11 Jun 24
Submission of Matters to a Vote of Security Holders
5:05pm
Seidenberg, M.D.
Proposal 2. Ratification of the Selection of Independent Registered Public Accounting Firm
The Company’s stockholders ratified … the selection by the Board's Audit Committee of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year
8-K
EX-10.1
SLRN
Acelyrin Inc
9 May 24
ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones
8:13am
as independent shadow counsel for Employee and to represent Employee in the event of any conflict of interest or potential conflict of interest arising
DEF 14A
SLRN
Acelyrin Inc
22 Apr 24
Definitive proxy
4:10pm
of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024; and
3.To conduct any other business … of the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal 2024
Affirmative vote
S-8
SLRN
Acelyrin Inc
28 Mar 24
Registration of securities for employees
4:43pm
Opinion of Cooley LLP.
Consent of Cooley LLP (included in Exhibit 5.1).
Consent of PricewaterhouseCoopers LLP, independent registered public accounting firm
S-8
EX-23.2
pm3xgjauzuh8g91a285
28 Mar 24
Registration of securities for employees
4:43pm
10-K
EX-23.1
a8pfqxyfj2 t9
28 Mar 24
Annual report
4:21pm
10-K
ms8 u6y5b6av
28 Mar 24
Annual report
4:21pm
10-K
EX-97.1
1mque2p6jjoou bkx
28 Mar 24
Annual report
4:21pm
8-K
824ncdxlo4 b1v
11 Mar 24
ACELYRIN, INC. Announces Positive Top-line Results from Its Global Phase 2b/3 Clinical Trial of Izokibep in Psoriatic Arthritis
8:05am
8-K
EX-99.1
afz2b4a1j3prwv
27 Nov 23
ACELYRIN, INC. Provides Update on Izokibep Clinical Development Program
4:31pm
8-K
EX-99.1
pz6fnsig
14 Aug 23
ACELYRIN, INC. Reports Second Quarter 2023 Financial Results and Recent Highlights
4:22pm
8-K
EX-99.1
cs4bh
15 Jun 23
ACELYRIN, INC. Reports First Quarter 2023 Financial Results and Recent Highlights
4:22pm
10-Q
i22voocxkbsgks
15 Jun 23
Quarterly report
4:19pm
8-K
EX-3.2
qh057pmxynxp1cs
9 May 23
ACELYRIN, INC. Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
4:16pm
S-8
EX-23.4
vkpsnf6l7tzp7 fe
8 May 23
Registration of securities for employees
5:27pm
S-8
EX-23.3
d5ort9
8 May 23
Registration of securities for employees
5:27pm
S-8
EX-23.2
xahngxd3 89p4
8 May 23
Registration of securities for employees
5:27pm